Want to see RLMD full AI Analyst Report?
Relmada Therapeutics (RLMD) Q2 2024 Earnings Report
RLMD Q2 2024 EPS Results
- Actual EPS
- -$0.59
- Consensus EPS
- -$0.83
- Beat/Miss
- Beat by +$0.24
- One Year Ago EPS
- -$0.84
RLMD Q2 2024 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/07/2024
- Time
- After Close
- Conference Call
- Wednesday, August 7, 2024
RLMD Upcoming Earnings
Relmada Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
RLMD Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
RLMD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -0.14- | -0.3 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -0.20-0.11 | -0.3 | 63.33% (+0.19) | |
| May 12, 2026 | 2026 (Q1) | -0.20-0.22 | -0.58 | 62.07% (+0.36) | |
| Mar 19, 2026 | 2025 (Q4) | -0.15-0.27 | -0.62 | 56.45% (+0.35) | |
| Nov 13, 2025 | 2025 (Q3) | -0.42-0.30 | -0.72 | 58.33% (+0.42) | |
| Aug 07, 2025 | 2025 (Q2) | -0.46-0.30 | -0.59 | 49.15% (+0.29) | |
| May 12, 2025 | 2025 (Q1) | -0.48-0.58 | -0.72 | 19.44% (+0.14) | |
| Mar 27, 2025 | 2024 (Q4) | -0.67-0.62 | -0.84 | 26.19% (+0.22) | |
| Nov 07, 2024 | 2024 (Q3) | -0.68-0.72 | -0.73 | 1.37% (+0.01) | |
| Aug 07, 2024 | 2024 (Q2) | -0.83-0.59 | -0.84 | 29.76% (+0.25) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
